Ibudilast modulates platelet-endothelium interaction mainly through cyclic GMP-dependent mechanism

Journal of Cardiovascular Pharmacology

Volumn 36, Issue 1, 2000, Pages 65-70

  Kishi, Yukio ^a   Ohta, Seiko ^a   Kasuya, Natsuko ^a   Tatsumi, Masahiro ^a   Sawada, Mitsunori ^a   Sakita, Shinya ^a   Ashikaga, Takashi ^a   Numano, Fujio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

ATP diphosphohydrolase; Cyclic GMP; Ibudilast; Nitric oxide; Phosphodiesterase; Platelet

Indexed keywords

ACETYLSALICYLIC ACID; CYCLIC GMP; IBUDILAST; N(G) NITROARGININE;

ANIMAL CELL; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; FETUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION INHIBITION; VASCULAR ENDOTHELIUM;

EID: 0033918588     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200007000-00009     Document Type: Article

References (5)

1. Ware JA, Heistad DD. Platelet-endothelium interactions. N Engl J Med 1993;328:628-35.
2. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43: 109-42.
3. Radomski MW, Palmer RMJ, Moncada S. The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 1987;148:1482-9.
4. Hagiwara M, Endo T, Hidaka H. Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscle. Biochem Pharmacol 1984;33:453-7.
5. Bull H, Fret HR, Jordaens FH, Herman AG. Dipyridamole potentiates platelet inhibition by nitric oxide. Thromb Haemost 1991; 66:343-9.